Gene Therapy Weekly is the most comprehensive publication covering gene research for disease treatment and drug development.
Not only does Gene Therapy Weekly bring you more reports, but more coverage of every aspect of gene therapy research, from drug candidate identification through launch and beyond.
Published weekly, each issue of Gene Therapy Weekly has an average of more than 85 articles that cover gene therapy research from A-Z, including antisense technology, cancer gene therapies, recombinant antibodies, associated genomics studies, vector development and other gene delivery systems, as well as pertinent genetic, proteomic and cell biology studies.
But important gene therapy research news is only half the picture. Gene Therapy Weekly also provides key business intelligence regarding marketing, distribution, licensing, regulatory actions, personnel and funding for the pharmaceutical and biotech companies involved in gene therapy research and drug manufacturing.
NewsRx editors collect coverage from more than 4,000 peer-reviewed journals, dozens of industry meetings, medical news wires, pharmaceutical and biotech company internet sites, purchased databases, and press releases.
Each article, usually no more than 500 words, is written to be an information-heavy, concise report of the important facts, together with full references and citations for original source material. You get a fast, user-friendly read that keeps you on top of all the important gene therapy research-related developments for that week.
Gene Therapy Weekly is available in print or online at www.NewsRx.com. Email versions can be delivered directly to your desktop. Site licenses are also available for corporate use.
Combination print and email subscriptions are available, and all subscriptions come with online access to Gene Therapy Weekly's archives, which go back to 1995. See a sample issue here
Gene Therapy Weekly was the first and only newsletters dedicated solely to gene therapy reporting. We stake our 20-plus year history as a healthcare publisher that it remains the best.
But don't take our word for it. Sign up for our six-week, no-risk free trial and see for yourself. Receive six issues of Gene Therapy Weekly, more than 500 articles, and see why it will become your indispensable tool for tracking gene therapy research news and developments.
Subscribe now and we'll give you $300 off our regular subscription price. You get the power of the most comprehensive gene therapy research coverage in the industry at a great discount.
Start today, and eliminate all those hours you normally spend scanning dozens of periodicals, websites, and other information sources. We've done it for you; Gene Therapy Weekly has got you covered.
|
2009
